Oncocytic change in pleomorphic adenoma: molecular evidence in support of an origin in neoplastic cells

Background: Cells with oncocytic change (OC) are a common finding in salivary glands (SGs) and in SG tumours. When found within pleomorphic adenomas (PAs), cells with OC may be perceived as evidence of malignancy, and lead to a misdiagnosis of carcinoma ex pleomorphic adenoma (CaExPa). Aim: To describe a case of PA with atypical OC, resembling a CaExPa. A genomewide molecular analysis was carried out to compare the molecular genetic features of the two components and to determine whether the oncocytic cells originated from PA cells, entrapped normal cells, or whether these cells constitute an independent tumour. Materials and methods: Representative blocks were immunohistochemically analysed with antibodies raised against cytokeratin (Ck) 5/6, Ck8/18, Ck14, vimentin, p63, α-smooth muscle actin (ASMA), S100 protein, anti-mitochondria antibody, β-catenin, HER2, Ki67, p53 and epidermal growth factor receptor. Typical areas of PA and OC were microdissected and subjected to microarray-based comparative genomic hybridisation (aCGH). Chromogenic in situ hybridisation (CISH) was performed with in-house generated probes to validate the aCGH findings. Results: PA cells showed the typical immunohistochemical profile, including positivity for Ck5/6, Ck8/18, Ck14, vimentin, ASMA, S100 protein, p63, epidermal growth factor receptor and β-catenin, whereas oncocytic cells showed a luminal phenotype, expression of anti-mitochondria antibody and reduced β-catenin staining. Both components showed low proliferation rates and lacked p53 reactivity. aCGH revealed a similar amplification in both components, mapping to 12q13.3–q21.1, which was further validated by CISH. No HER2 gene amplification or overexpression was observed. The foci of oncocytic metaplasia showed an additional low-level gain of 6p25.2–p21.31. Conclusion: The present data demonstrate that the bizarre atypical cells of the present case show evidence of clonality but no features of malignancy. In addition, owing to the presence of a similar genome amplification pattern in both components, it is proposed that at least in some cases, OC may originate from PA cells.

[1]  A. Ashworth,et al.  Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity , 2005, The Journal of pathology.

[2]  G. Stenman.  Fusion oncogenes and tumor type specificity--insights from salivary gland tumors. , 2005, Seminars in cancer biology.

[3]  I. Leivo,et al.  Non‐invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER‐2/neu and MIB1 immunohistochemistry , 2005, Histopathology.

[4]  E. Fonseca,et al.  Hürthle (Oncocytic) Cell Tumors of Thyroid: Etiopathogenesis, Diagnosis and Clinical Significance , 2005, International journal of surgical pathology.

[5]  Emmanuel Barillot,et al.  Analysis of array CGH data: from signal ratio to gain and loss of DNA regions , 2004, Bioinform..

[6]  P. Raychaudhuri,et al.  Cul4A Physically Associates with MDM2 and Participates in the Proteolysis of p53 , 2004, Cancer Research.

[7]  V. Trovisco,et al.  BRAF mutations are associated with some histological types of papillary thyroid carcinoma , 2004, The Journal of pathology.

[8]  P. Raychaudhuri,et al.  Cul 4 A Physically Associates with MDM 2 and Participates in the Proteolysis of p 53 , 2004 .

[9]  Guillermina Lozano,et al.  MDM2, an introduction. , 2003, Molecular cancer research : MCR.

[10]  Masakazu Ueda,et al.  TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas , 2002, Hepatology.

[11]  M. Stanley.  Selected Problems in Fine Needle Aspiration of Head and Neck Masses , 2002, Modern Pathology.

[12]  J. Bullerdiek,et al.  Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma. , 2002, The American journal of pathology.

[13]  F. Barr,et al.  Molecular Pathogenesis of Rhabdomyosarcoma , 2002, Cancer biology & therapy.

[14]  H. Tanke,et al.  Characterization of chromosome aberrations in salivary gland tumors by FISH, including multicolor COBRA‐FISH , 2001, Genes, chromosomes & cancer.

[15]  M. Sobrinho-Simões,et al.  Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance , 2000, Virchows Archiv.

[16]  D. Gisselsson,et al.  Locus‐specific multifluor FISH analysis allows physical characterization of complex chromosome abnormalities in neoplasia , 2000, Genes, chromosomes & cancer.

[17]  M. Lingen,et al.  Differentiation and the cytomorphology of salivary gland tumors with specific reference to oncocytic metaplasia. , 1999, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[18]  Y. Takeda.  An immunohistochemical study of bizarre neoplastic cells in pleomorphic adenoma: Its cytological nature and proliferative activity , 1999, Pathology international.

[19]  P. D. Dal Cin,et al.  HMGI(Y) and HMGI-C dysregulation: a common occurrence in human tumors. , 1999, Advances in anatomic pathology.

[20]  P. Rogalla,et al.  Pleomorphic adenomas of the salivary glands: absence of HMGIY rearrangements. , 1999, Cancer genetics and cytogenetics.

[21]  I. Leivo,et al.  Oncocytic myoepithelioma and pleomorphic adenoma of the salivary glands , 1999, Virchows Archiv.

[22]  O. Nappi,et al.  Oxyphilic proliferations of the respiratory tract and paranasal sinuses. , 1999, Seminars in diagnostic pathology.

[23]  M. Papotti,et al.  Oncocytic and oncocytoid tumors of the exocrine pancreas, liver, and gastrointestinal tract. , 1999, Seminars in diagnostic pathology.

[24]  Z. Baloch,et al.  Oncocytic Lesions of the Neuroendocrine System , 1999, Seminars in diagnostic pathology.

[25]  A. Huvos,et al.  Oncocytic and oncocytoid tumors of the salivary glands. , 1999, Seminars in diagnostic pathology.

[26]  P. Rao,et al.  Nonsyntenic amplification of MYC with CDK4 and MDM2 in a malignant mixed tumor of salivary gland. , 1998, Cancer genetics and cytogenetics.

[27]  W. Kuo,et al.  The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers. , 1998, Cancer research.

[28]  W. V. D. Van de Ven,et al.  Molecular characterization of a complex chromosomal rearrangement in a pleomorphic salivary gland adenoma involving the 3'-UTR of HMGIC. , 1997, Cancer genetics and cytogenetics.

[29]  W. V. D. Van de Ven,et al.  In a Pleomorphic Adenoma of the Parotid Gland Fhit and Hmgic Expression of Reciprocal Hybrid Transcripts of Updated Version Citing Articles E-mail Alerts Expression of Reciprocal Hybrid Transcripts of Hmgic and Fhit in a Pleomorphic Adenoma of the Parotid Gland' , 2013 .

[30]  Auclair Pl,et al.  Atypical features in salivary gland mixed tumors: their relationship to malignant transformation. , 1996 .

[31]  G. Ellis,et al.  Atypical features in salivary gland mixed tumors: their relationship to malignant transformation. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[32]  V. Collins.  Gene amplification in human gliomas , 1995, Glia.

[33]  N. Stylopoulos,et al.  Oncocytic differentiation in salivary gland tumours , 1995, The Journal of Laryngology & Otology.

[34]  Gnepp Dr.  Malignant mixed tumors of the salivary glands: a review. , 1993 .

[35]  D. Gnepp.  Malignant mixed tumors of the salivary glands: a review. , 1993, Pathology annual.

[36]  J. Eveson,et al.  Oncocytic adenomas and oncocytic hyperplasia of salivary glands: a clinicopathological study of 26 cases , 1990, Histopathology.

[37]  C. Micheau,et al.  Histology of the major salivary glands. , 1989, The American journal of surgical pathology.

[38]  Butler.  ROYAL SURREY COUNTY HOSPITAL. , 1876 .